PTPN11 and Noonan syndrome: The increased preference for the open conformation in both Noonan and LEOPARD syndrome mutations promotes the protective ‘arm’ of SHP2 signaling, whereas only Noonan syndrome mutations retain the catalytic activity needed to drive the substrate-dependent features of signaling.